The EU HTA Regulation: How It Threatens Device Launches And Where The Solutions Lie
Executive Summary
Medtech needs to closely monitor how the newly adopted EU HTA Regulation is rolled out and actively seek to influence its impact to avoid major obstacles ahead. MedTech Europe’s Oliver Bisazza explains why further shaping of this new text is so critical.
You may also be interested in...
What Does The EU Regulation On HTA Mean For Medtech And When Will It Apply?
Several updates have come in recent weeks on the European Commission’s planned new Regulation on HTA, including a list of stakeholder members and updated rolling timeline. Medtech Insight explains how and when this legislation will affect the medtech sector.
French Medtech Reimbursement - How Added Value And Clinical Benefit Sway Decisions
In France, many medical devices require value assessments prior to securing market access, a process that manufacturers may find complex. Hubert Galmiche, head of medical device assessment at the French National Authority for Health (HAS) explains what the outcomes of these appraisals mean for companies.
MedTech Forum 2022: Bernasconi Mulls HTA Proposal, Speaks On New Device And Diagnostic Regs
The Medical Device and IVD Regulations are much needed, although solutions must be found quickly to address major problems created on the way. But the HTA Regulation works against the sector, MedTech Europe’s Serge Bernasconi said in a recent interview.